Royalty Pharma PLCNASDAQ:RPRX
- LAST PRICE28.3800
- TODAY'S CHANGE (%)0.2900 (1.0324%)
- Bid / Lots28.0600/ 1
- Ask / Lots28.6800/ 1
- Open / Previous Close28.3100 / 28.0900
- Day Range
- 52 Week Range
- Volume2,033,673
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RPRX |
|---|---|---|
| 09:32 ET | 41451 | 28.14 |
| 09:34 ET | 6887 | 28.14 |
| 09:36 ET | 2418 | 28.18 |
| 09:38 ET | 2542 | 28.21 |
| 09:39 ET | 1925 | 28.19 |
| 09:41 ET | 4709 | 28.12 |
| 09:43 ET | 3310 | 28.17 |
| 09:45 ET | 4511 | 28.205 |
| 09:48 ET | 4745 | 28.25 |
| 09:50 ET | 3419 | 28.25 |
| 09:52 ET | 1529 | 28.24 |
| 09:54 ET | 1500 | 28.31 |
| 09:56 ET | 4700 | 28.35 |
| 09:57 ET | 122870 | 28.51 |
| 09:59 ET | 15137 | 28.43 |
| 10:01 ET | 8488 | 28.475 |
| 10:03 ET | 4656 | 28.43 |
| 10:06 ET | 8835 | 28.44 |
| 10:08 ET | 6505 | 28.5 |
| 10:10 ET | 3709 | 28.51 |
| 10:12 ET | 17032 | 28.54 |
| 10:14 ET | 6027 | 28.48 |
| 10:15 ET | 5768 | 28.51 |
| 10:17 ET | 2600 | 28.48 |
| 10:19 ET | 400 | 28.48 |
| 10:21 ET | 5395 | 28.49 |
| 10:24 ET | 2023 | 28.46 |
| 10:26 ET | 2025 | 28.455 |
| 10:28 ET | 5952 | 28.46 |
| 10:30 ET | 7815 | 28.42 |
| 10:32 ET | 6095 | 28.38 |
| 10:33 ET | 5163 | 28.41 |
| 10:35 ET | 840 | 28.405 |
| 10:37 ET | 2844 | 28.425 |
| 10:39 ET | 2656 | 28.48 |
| 10:42 ET | 3455 | 28.45 |
| 10:44 ET | 4359 | 28.475 |
| 10:46 ET | 892 | 28.46 |
| 10:48 ET | 1167 | 28.464 |
| 10:50 ET | 12878 | 28.465 |
| 10:51 ET | 5756 | 28.505 |
| 10:53 ET | 3793 | 28.465 |
| 10:55 ET | 4573 | 28.41 |
| 10:57 ET | 400 | 28.41 |
| 11:00 ET | 7676 | 28.46 |
| 11:02 ET | 3284 | 28.45 |
| 11:04 ET | 6222 | 28.45 |
| 11:06 ET | 2800 | 28.44 |
| 11:08 ET | 1000 | 28.46 |
| 11:09 ET | 3100 | 28.46 |
| 11:11 ET | 2394 | 28.455 |
| 11:13 ET | 6054 | 28.4893 |
| 11:15 ET | 2464 | 28.505 |
| 11:18 ET | 1000 | 28.5001 |
| 11:20 ET | 3521 | 28.475 |
| 11:22 ET | 899 | 28.48 |
| 11:24 ET | 919 | 28.4803 |
| 11:26 ET | 8423 | 28.48 |
| 11:27 ET | 103439 | 28.495 |
| 11:29 ET | 100 | 28.49 |
| 11:31 ET | 3731 | 28.5 |
| 11:33 ET | 1354 | 28.5 |
| 11:36 ET | 371 | 28.49 |
| 11:38 ET | 4231 | 28.5 |
| 11:40 ET | 700 | 28.485 |
| 11:42 ET | 700 | 28.4825 |
| 11:44 ET | 21066 | 28.5 |
| 11:45 ET | 4239 | 28.5 |
| 11:47 ET | 100 | 28.5 |
| 11:49 ET | 36298 | 28.485 |
| 11:51 ET | 15761 | 28.47 |
| 11:54 ET | 2491 | 28.475 |
| 11:56 ET | 10409 | 28.41 |
| 11:58 ET | 4954 | 28.4102 |
| 12:00 ET | 4459 | 28.39 |
| 12:02 ET | 4861 | 28.39 |
| 12:03 ET | 2293 | 28.39 |
| 12:05 ET | 1711 | 28.39 |
| 12:07 ET | 1824 | 28.39 |
| 12:09 ET | 3142 | 28.365 |
| 12:12 ET | 2749 | 28.33 |
| 12:14 ET | 2112 | 28.31 |
| 12:16 ET | 700 | 28.315 |
| 12:18 ET | 17102 | 28.275 |
| 12:20 ET | 4083 | 28.24 |
| 12:21 ET | 16645 | 28.28 |
| 12:23 ET | 5101 | 28.32 |
| 12:25 ET | 600 | 28.33 |
| 12:27 ET | 2336 | 28.3 |
| 12:30 ET | 3945 | 28.33 |
| 12:32 ET | 1847 | 28.3 |
| 12:34 ET | 400 | 28.29 |
| 12:36 ET | 2254 | 28.29 |
| 12:38 ET | 600 | 28.3 |
| 12:39 ET | 300 | 28.3 |
| 12:41 ET | 1943 | 28.3 |
| 12:45 ET | 1732 | 28.325 |
| 12:48 ET | 3070 | 28.315 |
| 12:50 ET | 783 | 28.315 |
| 12:52 ET | 633 | 28.315 |
| 12:54 ET | 1574 | 28.31 |
| 12:56 ET | 6171 | 28.295 |
| 12:57 ET | 10205 | 28.29 |
| 12:59 ET | 1890 | 28.315 |
| 01:01 ET | 1100 | 28.3 |
| 01:03 ET | 2490 | 28.285 |
| 01:06 ET | 400 | 28.285 |
| 01:08 ET | 3270 | 28.31 |
| 01:10 ET | 1300 | 28.3 |
| 01:12 ET | 3803 | 28.28 |
| 01:14 ET | 2889 | 28.28 |
| 01:15 ET | 401 | 28.285 |
| 01:17 ET | 1182 | 28.28 |
| 01:19 ET | 1281 | 28.28 |
| 01:21 ET | 5401 | 28.27 |
| 01:24 ET | 7783 | 28.29 |
| 01:26 ET | 4099 | 28.285 |
| 01:28 ET | 454 | 28.285 |
| 01:30 ET | 2791 | 28.265 |
| 01:32 ET | 5031 | 28.28 |
| 01:33 ET | 100 | 28.275 |
| 01:35 ET | 3907 | 28.295 |
| 01:37 ET | 800 | 28.3 |
| 01:39 ET | 401 | 28.295 |
| 01:42 ET | 3848 | 28.33 |
| 01:44 ET | 2621 | 28.31 |
| 01:46 ET | 2185 | 28.325 |
| 01:48 ET | 522 | 28.325 |
| 01:50 ET | 3976 | 28.36 |
| 01:51 ET | 609 | 28.355 |
| 01:53 ET | 28649 | 28.405 |
| 01:55 ET | 1362 | 28.405 |
| 01:57 ET | 1647 | 28.405 |
| 02:00 ET | 12906 | 28.435 |
| 02:02 ET | 12619 | 28.44 |
| 02:04 ET | 19968 | 28.445 |
| 02:06 ET | 5024 | 28.425 |
| 02:08 ET | 4103 | 28.39 |
| 02:09 ET | 2540 | 28.4 |
| 02:11 ET | 5249 | 28.4 |
| 02:13 ET | 1579 | 28.38 |
| 02:15 ET | 7430 | 28.4 |
| 02:18 ET | 1900 | 28.4 |
| 02:20 ET | 104442 | 28.38 |
| 02:22 ET | 3898 | 28.395 |
| 02:24 ET | 1147 | 28.39 |
| 02:26 ET | 662 | 28.39 |
| 02:27 ET | 4456 | 28.375 |
| 02:29 ET | 200 | 28.375 |
| 02:31 ET | 1875 | 28.4 |
| 02:33 ET | 3239 | 28.42 |
| 02:36 ET | 1986 | 28.44 |
| 02:38 ET | 1700 | 28.455 |
| 02:40 ET | 3261 | 28.46 |
| 02:42 ET | 1089 | 28.47 |
| 02:44 ET | 924 | 28.47 |
| 02:45 ET | 2562 | 28.48 |
| 02:47 ET | 6970 | 28.5 |
| 02:49 ET | 150 | 28.4912 |
| 02:51 ET | 5894 | 28.455 |
| 02:54 ET | 2055 | 28.455 |
| 02:56 ET | 5473 | 28.475 |
| 02:58 ET | 1904 | 28.48 |
| 03:00 ET | 2990 | 28.485 |
| 03:02 ET | 24769 | 28.49 |
| 03:03 ET | 3168 | 28.4779 |
| 03:05 ET | 1289 | 28.47 |
| 03:07 ET | 22242 | 28.49 |
| 03:09 ET | 1849 | 28.49 |
| 03:12 ET | 700 | 28.485 |
| 03:14 ET | 1570 | 28.495 |
| 03:16 ET | 1674 | 28.5 |
| 03:18 ET | 3515 | 28.475 |
| 03:20 ET | 3754 | 28.475 |
| 03:21 ET | 5256 | 28.48 |
| 03:23 ET | 7672 | 28.46 |
| 03:25 ET | 1200 | 28.455 |
| 03:27 ET | 13554 | 28.45 |
| 03:30 ET | 21027 | 28.435 |
| 03:32 ET | 4105 | 28.41 |
| 03:34 ET | 7404 | 28.435 |
| 03:36 ET | 7153 | 28.435 |
| 03:38 ET | 6582 | 28.41 |
| 03:39 ET | 11321 | 28.375 |
| 03:41 ET | 14120 | 28.375 |
| 03:43 ET | 6661 | 28.375 |
| 03:45 ET | 1855 | 28.375 |
| 03:48 ET | 8051 | 28.355 |
| 03:50 ET | 6433 | 28.355 |
| 03:52 ET | 30603 | 28.335 |
| 03:54 ET | 27248 | 28.335 |
| 03:56 ET | 36695 | 28.31 |
| 03:57 ET | 37569 | 28.385 |
| 03:59 ET | 51417 | 28.38 |
Today
Royalty Pharma to Present at Upcoming Investor Conferences, from 10 hours ago by Dow Jones
10 hours ago by Dow Jones
May 9, 2024
Royalty Pharma Reports First Quarter 2024 Results, from 7:00AM ET on Thursday May 09, 2024 by Dow Jones
7:00AM ET on Thursday May 09, 2024 by Dow Jones*DJ Royalty Pharma 1Q Net $5M >RPRX, from 7:00AM ET on Thursday May 09, 2024 by Dow Jones
7:00AM ET on Thursday May 09, 2024 by Dow JonesRoyalty Pharma to Acquire Royalty Interest in Sanofi's Frexalimab, from 6:45AM ET on Thursday May 09, 2024 by Dow Jones
6:45AM ET on Thursday May 09, 2024 by Dow JonesPress Release: Royalty Pharma to Acquire Royalty Interest in Sanofi's Frexalimab, from 6:45AM ET on Thursday May 09, 2024 by Dow Jones
6:45AM ET on Thursday May 09, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Royalty Pharma PLC | 16.8B | 15.9x | +1.83% |
Amneal Pharmaceuticals Inc | 2.1B | -11.9x | --- |
Catalent Inc | 10.1B | -8.6x | --- |
Jazz Pharmaceuticals PLC | 6.9B | 23.3x | -3.53% |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Prestige Consumer Healthcare Inc | 3.5B | -43.0x | --- |
Company Information
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.
Contact Information
- Headquarters
- 110 East 59th StreetNEW YORK, NY, United States 10022
- Phone
- 212-883-0200
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Pablo Legorreta
- Vice Chairman, Executive Vice President
- Christopher Hite
- Chief Financial Officer, Executive Vice President
- Terrance Coyne
- Executive Vice President - Investments and Chief Legal Officer
- George Lloyd
- Executive Vice President - Research and Investments
- Marshall Urist
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $16.8B |
|---|---|
Revenue (TTM) | $2.2B |
Shares Outstanding | 597.4M |
Dividend Yield | 2.96% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 05-16-24 |
Pay Date | 06-14-24 |
Beta | 0.47 |
EPS | $1.78 |
Book Value | $14.61 |
P/E Ratio | 15.9x |
Price/Sales (TTM) | 7.5 |
Price/Cash Flow (TTM) | 14.1x |
Operating Margin | 41.96% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
